S.P. Conway

5.3k total citations · 1 hit paper
90 papers, 3.9k citations indexed

About

S.P. Conway is a scholar working on Pulmonary and Respiratory Medicine, Epidemiology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, S.P. Conway has authored 90 papers receiving a total of 3.9k indexed citations (citations by other indexed papers that have themselves been cited), including 64 papers in Pulmonary and Respiratory Medicine, 20 papers in Epidemiology and 14 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in S.P. Conway's work include Cystic Fibrosis Research Advances (60 papers), Child Nutrition and Feeding Issues (9 papers) and Respiratory viral infections research (8 papers). S.P. Conway is often cited by papers focused on Cystic Fibrosis Research Advances (60 papers), Child Nutrition and Feeding Issues (9 papers) and Respiratory viral infections research (8 papers). S.P. Conway collaborates with scholars based in United Kingdom, Ireland and Netherlands. S.P. Conway's co-authors include K. Brownlee, J M Littlewood, Miles Denton, Tim Lee, Alison Morton, Niels Høiby, Harry Heijerman, C. Etherington, D. Peckham and Gerd Döring and has published in prestigious journals such as American Journal of Respiratory and Critical Care Medicine, PEDIATRICS and Spine.

In The Last Decade

S.P. Conway

89 papers receiving 3.8k citations

Hit Papers

Evaluation of a new defin... 2003 2026 2010 2018 2003 100 200 300 400 500

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
S.P. Conway 2.8k 774 515 515 344 90 3.9k
A.K. Webb 3.0k 1.1× 533 0.7× 675 1.3× 227 0.4× 284 0.8× 125 4.2k
Harry Heijerman 3.8k 1.3× 826 1.1× 709 1.4× 545 1.1× 325 0.9× 145 5.0k
Peter J. Mogayzel 3.4k 1.2× 839 1.1× 460 0.9× 241 0.5× 216 0.6× 110 4.5k
Robert W. Wilmott 2.5k 0.9× 666 0.9× 502 1.0× 216 0.4× 158 0.5× 108 3.8k
Nicole Mayer-Hamblett 4.1k 1.5× 901 1.2× 997 1.9× 513 1.0× 148 0.4× 105 5.3k
M.E. Hodson 4.0k 1.4× 587 0.8× 616 1.2× 276 0.5× 220 0.6× 111 5.2k
Karen McCoy 4.7k 1.7× 890 1.1× 1.2k 2.2× 368 0.7× 227 0.7× 153 6.3k
Jeffrey S. Wagener 5.2k 1.9× 926 1.2× 845 1.6× 185 0.4× 316 0.9× 98 6.3k
Anne Malfroot 1.4k 0.5× 767 1.0× 544 1.1× 415 0.8× 101 0.3× 125 3.0k
Beryl J. Rosenstein 4.8k 1.7× 686 0.9× 714 1.4× 121 0.2× 321 0.9× 108 6.8k

Countries citing papers authored by S.P. Conway

Since Specialization
Citations

This map shows the geographic impact of S.P. Conway's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S.P. Conway with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S.P. Conway more than expected).

Fields of papers citing papers by S.P. Conway

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S.P. Conway. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S.P. Conway. The network helps show where S.P. Conway may publish in the future.

Co-authorship network of co-authors of S.P. Conway

This figure shows the co-authorship network connecting the top 25 collaborators of S.P. Conway. A scholar is included among the top collaborators of S.P. Conway based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S.P. Conway. S.P. Conway is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Morton, Alison, et al.. (2015). Longitudinal impact of demographic and clinical variables on health-related quality of life in cystic fibrosis. BMJ Open. 5(5). e007418–e007418. 26 indexed citations
2.
Etherington, C., et al.. (2013). The role of respiratory viruses in adult patients with cystic fibrosis receiving intravenous antibiotics for a pulmonary exacerbation. Journal of Cystic Fibrosis. 13(1). 49–55. 46 indexed citations
3.
Etherington, C., Scott F. Huntington, S.P. Conway, & D. Peckham. (2012). 294 Survey of contraceptive practices in women attending a large regional UK centre. Journal of Cystic Fibrosis. 11. S132–S132. 3 indexed citations
4.
Haworth, Charles, Linda Sharples, Vikki Hughes, et al.. (2011). Multicentre trial of weekly risedronate on bone density in adults with cystic fibrosis. Journal of Cystic Fibrosis. 10(6). 470–476. 15 indexed citations
5.
Peckham, D., et al.. (2010). Cystic fibrosis co-existing with trisomy 21. Journal of Cystic Fibrosis. 9(5). 330–331. 4 indexed citations
6.
Abbott, Janice, et al.. (2009). What defines a pulmonary exacerbation? The perceptions of adults with cystic fibrosis. Journal of Cystic Fibrosis. 8(5). 356–359. 30 indexed citations
7.
Clifton, I., Louise A. Fletcher, Clive Beggs, et al.. (2009). An aerobiological model of aerosol survival of different strains of Pseudomonas aeruginosa isolated from people with cystic fibrosis. Journal of Cystic Fibrosis. 9(1). 64–68. 22 indexed citations
8.
White, H., C. Etherington, I. Clifton, et al.. (2009). Nutritional decline in cystic fibrosis related diabetes: The effect of intensive nutritional intervention. Journal of Cystic Fibrosis. 8(3). 179–185. 32 indexed citations
9.
Hind, Karen, J G Truscott, & S.P. Conway. (2008). Exercise during childhood and adolescence: A prophylaxis against cystic fibrosis-related low bone mineral density?. Journal of Cystic Fibrosis. 7(4). 270–276. 37 indexed citations
10.
Lee, Tim, et al.. (2008). Regimens for eradicating early Pseudomonas aeruginosa infection in children do not promote antibiotic resistance in this organism. Journal of Cystic Fibrosis. 8(1). 43–46. 14 indexed citations
11.
Morton, Alison, et al.. (2008). Microvascular complications in patients with cystic fibrosis-related diabetes (CFRD). Journal of Cystic Fibrosis. 7(6). 515–519. 71 indexed citations
12.
Hart, Anna, et al.. (2008). Can Health-related Quality of Life Predict Survival in Adults with Cystic Fibrosis?. American Journal of Respiratory and Critical Care Medicine. 179(1). 54–58. 50 indexed citations
14.
Conway, S.P., et al.. (2005). Risk factors for acquisition of methicillin-resistant Staphylococcus aureus (MRSA) by patients with cystic fibrosis. Journal of Cystic Fibrosis. 4(1). 49–52. 55 indexed citations
15.
White, H., Alison Morton, D. Peckham, & S.P. Conway. (2004). Dietary intakes in adult patients with cystic fibrosis–do they achieve guidelines?. Journal of Cystic Fibrosis. 3(1). 1–7. 36 indexed citations
16.
Duff, Alistair, et al.. (2003). Feeding Behavior Problems in Children With Cystic Fibrosis in the UK: Prevalence and Comparison With Healthy Controls. Journal of Pediatric Gastroenterology and Nutrition. 36(4). 443–447. 2 indexed citations
17.
Lee, Tim, K. Brownlee, S.P. Conway, Miles Denton, & J M Littlewood. (2003). Evaluation of a new definition for chronic Pseudomonas aeruginosa infection in cystic fibrosis patients. Journal of Cystic Fibrosis. 2(1). 29–34. 547 indexed citations breakdown →
18.
Conway, S.P., C. Etherington, D. Peckham, & Anne Whitehead. (2003). A pilot study of zafirlukast as an anti-inflammatory agent in the treatment of adults with cystic fibrosis. Journal of Cystic Fibrosis. 2(1). 25–28. 20 indexed citations
19.
Döring, Gerd, S.P. Conway, Harry Heijerman, et al.. (2000). Antibiotic therapy against Pseudomonas aeruginosa in cystic fibrosis: a European consensus. European Respiratory Journal. 16(4). 749–749. 463 indexed citations
20.
Conway, S.P., et al.. (1990). Prophylactic Intravenous Immunoglobulin in Pre‐Term Infants: A Controlled Trial. Vox Sanguinis. 59(1). 6–11. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026